Single-site robotic surgery in gynecologic cancer: a pilot study.
- Author:
Ha Na YOO
1
;
Tae Joong KIM
;
Yoo Young LEE
;
Chel Hun CHOI
;
Jeong Won LEE
;
Duk Soo BAE
;
Byoung Gie KIM
Author Information
- Publication Type:Original Article ; Evaluation Studies
- Keywords: Gynecology; Minimally Invasive Surgical Procedures; Operation Time; Postoperative Complications; Robotic Surgical Procedure; Single-site
- MeSH: Adult; Body Mass Index; Feasibility Studies; Female; Genital Neoplasms, Female/*surgery; Humans; Length of Stay/statistics & numerical data; Lymph Node Excision/methods; Middle Aged; Minimally Invasive Surgical Procedures/adverse effects/methods; Operative Time; Pilot Projects; Robotic Surgical Procedures/adverse effects/*methods; Treatment Outcome
- From:Journal of Gynecologic Oncology 2015;26(1):62-67
- CountryRepublic of Korea
- Language:English
- Abstract: OBJECTIVE: To discuss the feasibility of single-site robotic surgery for benign gynecologic tumors and early stage gynecologic cancers. METHODS: In this single institution, prospective analysis, we analyzed six patients who had undergone single-site robotic surgery between December 2013 and August 2014. Surgery was performed using the da Vinci Si Surgical System. Patient characteristics and surgical outcomes were analyzed. RESULTS: Single-site robotic surgery was performed successfully in all six cases. The median patient age was 48 years, and the median body mass index was 25.5 kg/m2 (range, 22 to 33 kg/m2). The median total operative time was 211 minutes, and the median duration of intracorporeal vaginal cuff suturing was 32 minutes (range, 22 to 47 minutes). The median duration of pelvic lymph node dissection was 31 minutes on one side and 27 minutes on the other side. Patients' postoperative courses were uneventful. The median postoperative hospital stay was 4 days. No postoperative complications occurred. CONCLUSION: When used to treat benign gynecologic tumors and early stage gynecologic cancers, the single-site da Vinci robotic surgery is feasible, safe, and produces favorable surgical outcomes.
